U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.

Shares of MercadoLibre Inc (NASDAQ:MELI) fell sharply in pre-market trading after Brazilian President Luiz Inácio Lula da Silva secured another term, defeating Sen. Flávio Bolsonaro.

The election result rattled investors and triggered a sell-off in Brazilian stocks.

MercadoLibre shares dipped 14.1% to $1,555.50 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• XP Inc (NASDAQ:XP) fell 46% to $16.43 in pre-market trading after gaining around 4% on Friday.
• Inter & Co Inc (NASDAQ:INTR) fell 34.7% to $4.69 in pre-market trading after gaining over 6% on Friday. Inter & Co, last week, announced Banco Inter will acquire the remaining 39.75% stake in Inter Seguros, giving it full ownership of the insurance unit.
• StoneCo Ltd (NASDAQ:STNE) fell 33.8% to $7.59 in pre-market trading after gaining around 3% on Friday.
• PagSeguro Digital Ltd (NYSE:PAGS) fell 29.2% to $8.10 in pre-market trading.
• Banco Bradesco SA (NYSE:BBD) tumbled 28.1% to $2.92 in pre-market trading. Bank Bradesco, last week, posted third-quarter earnings of 13 cents per share.
• Itaú Unibanco Holding S.A. (NYSE:ITUB) fell 25.6% to $7.19 in pre-market trading. High Roller Technologies recently announced the commercial launch of its real-money prediction markets platform ROLR.
• Nu Holdings Ltd. (NYSE:NU) fell 23.6% to $11.57 in pre-market trading.
• Petroleo Brasileiro (NYSE:PBR) dipped 22.6% to $20.25 in pre-market trading.
• Agi Inc (NYSE:AGBK) fell 21.5% to $5.95 in pre-market trading.
• Companhia de Saneamento Básico do Estado de São Paulo – SABESP (NYSE:SBS) declined 21.4% to $5.00 in pre-market trading.
• LATAM Airlines Group SA (NYSE:LTM) fell 9.2% to $42.00 in pre-market trading.
• Moderna Inc (NASDAQ:MRNA) dipped 8.6% to $183.00 in pre-market trading.
• Adaptive Biotechnologies Corp (NASDAQ:ADPT) declined 6% to $23.98 in pre-market trading. Adaptive Biotechnologies will report third quarter financial results on Nov. 4.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.